Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

epirubicin hydrochloride, Quantity: 2 mg/mL

Prieinama:

Hospira Australia Pty Ltd

INN (Tarptautinis Pavadinimas):

epirubicin hydrochloride

Vaisto forma:

Injection, solution

Sudėtis:

Excipient Ingredients: sodium chloride; water for injections

Vartojimo būdas:

Intravenous Infusion

Vienetai pakuotėje:

5 vials per pack

Klasė:

Medicine Listed (Export Only)

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

Produkto santrauka:

Visual Identification: Epirubicin Hydrochloride Injection is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Licence status A

Leidimo data:

2013-05-08